According to the group of authors, these polyagonists are in all likelihood the next step towards a cure for diabetes and obesity. Comparable to bariatric surgery The authors report on various polyagonists that are currently being researched in clinical studies and show improved efficacy with each new generation. The latest triple agonists attack both the glucose-dependent insulinotropic peptide receptor (GIPR) and the receptors for glucagon-like peptide 1 (GLP1) and glucagon (GCG, a hormone from the pancreas)
Reduced Glutathione provides glutathione in its biologically active reduced form for optimum absorption
doi: 10.1136/bmj.e1369
pp 125138 Fraschini F, Esposti D, Demartini G, Scaglione F, Lucini V, Mariani et al
Interestingly, interventions that boost NAD + levels resulted in extended lifespan in worms and mice 108,109,111,247 , suggesting a therapeutic potential for raising NAD + in various pathological conditions or age-associated diseases
Journal of Clinical Endocrinology and Metabolism, 97 ,
